Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

EMA – Improved scientific advice for medicines for public health threats including antimicrobial resistance

EMA’s Emergency Task Force (ETF) is improving its approach to scientific advice for the most promising medicines and vaccines under development for public health threats.

Under the new process, developers of medicines falling within the scope of the ETF’s activities, including medicines for antimicrobial resistance (AMR) and other health threats that have the potential to cause public health emergencies, can apply for combined scientific advice from EMA, as well as clinical trial and ethics experts at national level. As a result, requirements for clinical trials and marketing authorisation of medicines and vaccines for public health threats will be aligned at an early stage, which should lead to more rapid authorisation of clinical trials and of these medicines.

More information on the EMA Website.


OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (11 décembre 2025). EMA – Improved scientific advice for medicines for public health threats including antimicrobial resistance. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/15bv2


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.